Adaptimmune Therapeutics Plc (ADAP) Insider Trading

Total insider buys:
  • $80,274,368.40
Total insider sells:
  • $24,904,070.42
Most recent insider trade:
  • Aug. 1, 2022
Most active insider trader:
  • Adrian Rawcliffe
Trader NameDateTitleAmountPriceTypeTotal Value
Aug. 1, 2022Insider2,983$1.77Sell$5,279.91
July 5, 2022Insider1,973$1.68Sell$3,314.64
June 27, 2022CEO2,562$1.63Sell$4,176.06
May 20, 2022CFO39,000$0.29Buy$11,310.00
Jan. 18, 2022COO4,368$3.19Sell$13,933.92
Jan. 18, 2022Insider2,121$3.19Sell$6,765.99
Jan. 18, 2022CEO11,096$3.19Sell$35,396.24
Jan. 12, 2022Insider1,076$3.54Sell$3,809.04
Jan. 11, 2022COO3,770$3.56Sell$13,421.20
Jan. 11, 2022CEO14,362$3.56Sell$51,128.72
Jan. 4, 2022CEO5,532$4.06Sell$22,459.92
Jan. 4, 2022Insider1,070$4.06Sell$4,344.20
Jan. 4, 2022COO3,490$4.06Sell$14,169.40
Sept. 1, 2021CEO2,782$5.20Sell$14,466.40
Aug. 2, 2021Insider2,939$3.58Sell$10,521.62
June 28, 2021CEO2,794$4.37Sell$12,209.78
Jan. 19, 2021CEO9,879$5.67Sell$56,013.93
Jan. 19, 2021Insider2,111$5.67Sell$11,969.37
Jan. 12, 2021CEO2,707$6.15Sell$16,648.05
Jan. 12, 2021Insider1,058$6.15Sell$6,506.70
Jan. 12, 2021COO2,234$6.15Sell$13,739.10
Jan. 4, 2021CEO4,967$5.33Sell$26,474.11
Jan. 4, 2021Insider1,065$5.33Sell$5,676.45
Jan. 4, 2021COO3,499$5.33Sell$18,649.67
Dec. 14, 2020COO207,000$0.69Buy$142,830.00
Dec. 14, 2020CFO24,000$0.69Buy$16,560.00
Sept. 1, 2020CEO2,776$8.51Sell$23,623.76
Aug. 3, 2020CEO2,788$9.25Sell$25,789.00
Aug. 3, 2020Insider4,823$9.25Sell$44,612.75
June 29, 2020CFO33,000$1.62Buy$53,460.00
June 9, 2020Director12,900$1.89Buy$24,381.00
May 29, 2020Director500,000$9.33Sell$4,665,000.00
Jan. 24, 2020Major Shareholder7,500,000$0.67Buy$5,025,000.00
Jan. 14, 2020COO2,397$5.13Sell$12,296.61
Jan. 14, 2020CEO3,236$5.13Sell$16,600.68
Jan. 14, 2020Insider911$5.13Sell$4,673.43
Jan. 13, 2020Director300,000$4.67Sell$1,401,000.00
Jan. 6, 2020COO3,731$1.20Sell$4,477.20
Jan. 6, 2020CEO5,900$1.20Sell$7,080.00
Jan. 6, 2020Insider1,148$1.20Sell$1,377.60
Aug. 6, 2019Insider11,043$2.06Sell$22,748.58
Jan. 14, 2019COO2,271$5.37Sell$12,195.27
Jan. 14, 2019Insider3,028$5.37Sell$16,260.36
Jan. 14, 2019CTO1,514$5.37Sell$8,130.18
Jan. 14, 2019CFO3,084$5.37Sell$16,561.08
Dec. 17, 2018Director47,280$0.84Buy$39,715.20
Oct. 1, 2018Insider25,000$13.79Sell$344,750.00
Sept. 7, 2018Major Shareholder3,000,000$1.67Buy$5,010,000.00
Sept. 7, 2018Director12,000,000$1.67Buy$20,040,000.00
Aug. 29, 2018Insider25,000$10.25Sell$256,250.00
First«1 of 2»Last
  • Insiders are both buying and selling Adaptimmune Therapeutics Plc stock.

  • The insider traders at Adaptimmune Therapeutics Plc are: Adrian Rawcliffe, John Lunger, William C. Bertrand, Jr., Orbimed Advisors Llc, Enterprise Associates 14 New, William C Bertrand Jr, Gavin Wood, Gwendolyn Knowlt Binder-Scholl, Elliot Norry, Peter A Thompson, Lawrence M. Alleva, David M Mott, James Noble, Charles Elliott Sigal, Rafael Amado, Ravi Viswanathan, Peter W Sonsini, and Ali Behbahani

  • The most active insider trader at Adaptimmune Therapeutics Plc is Adrian Rawcliffe with 15 trades.

  • Orbimed Advisors Llc has sold the most Adaptimmune Therapeutics Plc stock with a total value of $14,870,124.50.

  • Ali Behbahani has bought the most Adaptimmune Therapeutics Plc stock with a total value of $40,080,000.00.

  • The most recent insider trade for Adaptimmune Therapeutics Plc was on Aug. 1, 2022.

  • The single biggest insider buy for Adaptimmune Therapeutics Plc was from Ali Behbahani with a total value of $20,040,000.00 on Sept. 7, 2018.

  • The single biggest insider sell for Adaptimmune Therapeutics Plc was from Orbimed Advisors Llc with a total value of $12,052,770.50 on March 29, 2018.